Digipath Inc.’s President, Todd Denkin Interviewed; Discusses the Cannabis Lab Business and Opportunities

Las Vegas, NV, Sept. 06, 2017 -- Todd Denkin President and COO of Digipath, Inc. (OTCQB:DIGP) was recently interviewed on the Uptick Network Stock Day Podcast by host Everett Jolly. Among other things, Mr. Denkin discussed the company’s plans for expansion and growth, the impact of Nevada’s legalization of recreational cannabis, the company’s focus on customer service, and the broad array of tests and services offered by the company.

To listen to the interview please click here or the following link: https://upticknewswire.com/featured-interview-ceo-todd-denkin-of-digipath-inc-otcqb-digp

About Digipath, Inc.
Digipath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath's two business units are Digipath Labs and TNM News Corp. Digipath Labs(TM) is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.

Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Source: Uptick Newswire

Contact 
Harrison Phillips 
Viridian Capital Advisors, LLC 
(212) 209-3086 
[email protected]